In women with nipple discharge, contrast breast MR has higheroverall sensitivity for detecting malignant and high-risk lesionsthan mammography or ultrasound.
In women with nipple discharge, contrast breast MR has higher overall sensitivity for detecting malignant and high-risk lesions than mammography or ultrasound.
Between March 2007 and July 2009, 38 women with nipple discharge underwent ultrasound, mammography, and contrast MR (1.5T). A malignant lesion was found in five of 38 patients. A high-risk lesion was found in 14 of 38 patients. Contrast MR found all five of the cancers and 13 of the 14 high-risk lesions for a sensitivity of 94.74%. Mammography had a sensitivity of 26.32%; ultrasound had a sensitivity of 63.16%.
Contrast MR should be recommended when conventional imaging is negative, according to Dr. Michele Lorenzon, from the radiology department at the University of Udine in Italy. The study was presented at the European Congress of Radiology in Vienna in March.
The Reading Room: Racial and Ethnic Minorities, Cancer Screenings, and COVID-19
November 3rd 2020In this podcast episode, Dr. Shalom Kalnicki, from Montefiore and Albert Einstein College of Medicine, discusses the disparities minority patients face with cancer screenings and what can be done to increase access during the pandemic.
Study Finds Transvaginal Ultrasound Unreliable for Detecting Endometrial Cancer in Black Patients
July 3rd 2024Utilizing a threshold of less than 5 mm of ultrasound-measured endometrial thickness, the authors of a new study noted an 11.4 percent false-negative probability for endometrial cancer in Black patients.
New Study Shows Non-Radiologists Interpreting 28 Percent of Imaging for Medicare Patients
June 28th 2024While radiologists interpreted approximately 99 percent of all non-cardiac CT, MRI and nuclear medicine studies in hospital and emergency department settings for Medicare beneficiaries, new research shows significantly less radiologist review of cardiac imaging and office-based imaging.
FDA Clears Pocket-Sized ECG System and AI Technology for Detection of Cardiac Conditions
June 27th 2024Using a reduced leadset and deep neural network algorithms trained on more than 175 million electrocardiograms, the KAI 12L technology reportedly detects up to 35 cardiac determinations, including acute myocardial infarction.